Syneron Medical Ltd., a global market leader in the aesthetic medical device marketplace, recently announced that it has received the United States Food and Drug Administration (FDA) 510(k) clearance to market the UltraShape™ System for non-invasive reduction of abdominal circumference via fat cell destruction.
